Skip to content
  • Koneksa Platform Login
Koneksa
  • Solutions
    • Leading Digital Biomarkers
    • CROs & DCT Partners
  • Therapeutic Focus
    • Neuroscience
    • Parkinson’s Disease
    • Oncology
    • Respiratory
    • Rare Diseases
    • Other Therapeutic Areas
  • Scientific Evidence
    • Clinical Pipeline
    • Publications
  • Resources
    • Resource Library
    • Our Blog
    • Digital Biomarkers FAQ
  • About Us
    • Background & Leadership
    • Our Partnerships
    • News
    • Events
    • Our Culture
  • Contact Us
  • Solutions
    • Leading Digital Biomarkers
    • CROs & DCT Partners
  • Therapeutic Focus
    • Neuroscience
    • Parkinson’s Disease
    • Oncology
    • Respiratory
    • Rare Diseases
    • Other Therapeutic Areas
  • Scientific Evidence
    • Clinical Pipeline
    • Publications
  • Resources
    • Resource Library
    • Our Blog
    • Digital Biomarkers FAQ
  • About Us
    • Background & Leadership
    • Our Partnerships
    • News
    • Events
    • Our Culture
  • Contact Us
  • Koneksa Platform Login
2022

2022

Blog

Koneksa’s 2022 Year in Review

December 24, 2022

Blog

Koneksa at the CNS Summit: Advancing Digital Biomarkers in Parkinson’s Disease Research

December 1, 2022

Blog

Digital Biomarker Collaborations Are Super-Charging Neuroscience

November 1, 2022

Blog

Reverse Translation Experts Gather in Zürich: Conference Recap

October 6, 2022

Blog

How Are Digital Biomarkers Reshaping Parkinson’s Disease Research?

September 23, 2022

Blog

The Koneksa Women’s Network: Building Community That Scales

August 9, 2022

Blog

Leveraging Digital Biomarkers to Transform CNS Clinical Research

August 4, 2022

Blog

What Do BYOD Trials Need to Succeed?

August 1, 2022

Blog

Koneksa CMO Speaks at FDA Workshop

July 5, 2022

Blog

Focus on Biomarker vs. eCOA

May 25, 2022

Posts navigation

1 2 Next

For the Measures That Matter for Your Trial, Partner With Koneksa

Contact Us
LOG INTO THE KONEKSA APP

© 2025 Koneksa Health. All Rights Reserved.

  • Privacy Policy
  • Contact Us
LinkedIn Twitter YouTube